These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22203431)

  • 41. [Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma].
    Rodríguez-Ruiz M; Tellado MG; del Pozo Losada J
    An Pediatr (Barc); 2016 Feb; 84(2):92-6. PubMed ID: 26002439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Periocular infantile haemangioma and the role of propranolol.
    Chaudhry TA; Kamal M; Ahmad K
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):593-5. PubMed ID: 23930881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D photography is a reliable method of measuring infantile haemangioma volume over time.
    Robertson SA; Kimble RM; Storey KJ; Gee Kee EL; Stockton KA
    J Pediatr Surg; 2016 Sep; 51(9):1552-6. PubMed ID: 27179423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propranolol (Hemangiol) and severe infantile haemangiomas. The drug of first choice.
    Prescrire Int; 2015 Jul; 24(162):173-6. PubMed ID: 26240880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine.
    Nutt JE; Durkan GC; Mellon JK; Lunec J
    BJU Int; 2003 Jan; 91(1):99-104. PubMed ID: 12614260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
    Moodley ST; Hudson DA; Adams S; Adams KG
    Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment failure with propranolol for subglottic haemangioma.
    Liu Z; Yeo YH; Jackson C; Trimble K
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31088811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemangioma in an infant whose mother was receiving long-term propranolol treatment during pregnancy.
    Méchineaud M; Nicaise D; Martin L
    Br J Dermatol; 2016 Feb; 174(2):464. PubMed ID: 26479419
    [No Abstract]   [Full Text] [Related]  

  • 50. Infantile haemangioma and β-blockers in otolaryngology.
    Leboulanger N; Cox A; Garabedian EN; Denoyelle F
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):236-40. PubMed ID: 21498145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Propranolol treatment for subglottic haemangioma.
    Guye E; Chollet-Rivier M; Schröder D; Sandu K; Hohlfeld J; de Buys Roessingh A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F263-4. PubMed ID: 21242239
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathogenesis of infantile haemangioma.
    Greenberger S; Bischoff J
    Br J Dermatol; 2013 Jul; 169(1):12-9. PubMed ID: 23668474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma.
    Hermans MM; Breugem CC; Schappin R; Jonge Poerink E; Mendels EJ; Ragamin A; Breur JMPJ; Langeveld HR; Raphael MF; De Laat PCJ; De Wildt SN; Rietman AB; Pasmans SGMA; De Graaf M
    Acta Derm Venereol; 2022 Oct; 102():adv00788. PubMed ID: 35506358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.
    Ji Y; Chen S; Xu C; Li L; Xiang B
    Br J Dermatol; 2015 Jan; 172(1):24-32. PubMed ID: 25196392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of infantile haemangioma with propranolol.
    Weissenstein A; Luchter E; Bittmann S
    Br J Nurs; 2015 Jan 22-Feb 11; 24(2):96-7. PubMed ID: 25615994
    [No Abstract]   [Full Text] [Related]  

  • 57. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.
    Lou Y; Peng WJ; Cao Y; Cao DS; Xie J; Li HH
    Br J Clin Pharmacol; 2014 Jul; 78(1):44-57. PubMed ID: 24033819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.